ketone idebenone PMID:33247801 PMID:19283350 CHEBI:31687 Drug_Central:1416 0 CV-2619 338.444 Patent:DE2519730 2,3-dimethoxy-5-methyl-6-(10'-hydroxydecyl)-1,4-benzoquinone PMID:11207459 2-(10-hydroxydecyl)-5,6-dimethoxy-3-methyl-1,4-benzoquinone idebenonum PMID:7981485 Patent:US4271083 InChI=1S/C19H30O5/c1-14-15(12-10-8-6-4-5-7-9-11-13-20)17(22)19(24-3)18(23-2)16(14)21/h20H,4-13H2,1-3H3 Chemspider:3558 PMID:30726629 PMID:22269948 PMID:23859348 PMID:33254077 PMID:33628024 6-(10-hydroxydecyl)-2,3-dimethoxy-5-methyl-p-benzoquinone PMID:7988944 PMID:18045357 PMID:32111141 DrugBank:DB09081 JGPMMRGNQUBGND-UHFFFAOYSA-N Wikipedia:Idebenone CV 2619 2-(10-hydroxydecyl)-5,6-dimethoxy-3-methyl-p-benzoquinone chebi_ontology C19H30O5 PMID:2669658 LINCS:LSM-5505 338.20932 CAS:58186-27-9 2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione PMID:20955109 PMID:15374364 PMID:19283347 Raxone KEGG:D01750 A member of the class of 1,4-benzoquinones which is substituted by methoxy groups at positions 2 and 3, by a methyl group at positions 5, and by a 10-hydroxydecyl group at positions 6. Initially developed for the treatment of Alzheimer's disease, benefits were modest; it was subsequently found to be of benefit for the symptomatic treatment of Friedreich's ataxia. idebenone PMID:18710357 6-(10-hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinone idebenona Reaxys:2001459 COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O